HCW Biologics is trading 5.98% up in after-hours trading at $3.10 after closing at $2.92 on August 13, 2026; no confirmed company-specific announcement or earnings release explaining the move was found.
- Earnings calendars provide conflicting estimated dates, including August 13 and August 17.
- The S&P 500 was up 0.68% and Nasdaq Composite up 0.98%.
- The stockβs regular-session decline leaves the catalyst unclear; confidence is low.